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INTRODUCTION HAMLET (Human α-lactalbumin Made LEthal to Tumor cells)
1 is a protein folding variant of α-lactalbumin with remarkable properties in cellular assays. It forms a molecular complex with oleic acid that induces cell death with selectivity for tumor cells and undifferentiated cells. The apoptotic activity of this complex was discovered by serendipity in a fraction of human milk casein (1) and the structural basis of this novel activity was studied by a combination of spectroscopic techniques and biological assays (2, 3) . HAMLET contains partially unfolded α-lactalbumin with native-like secondary structure, but lacking specific tertiary packing of the side chains. Oleic acid binds to the unfolded protein with a stereo-specific fit, and the hinge region between the α-helical and the β-sheet domains has been proposed as the fatty acid binding site 2 .
The link between apoptosis induction and the folding change was proven by deliberate conversion of native α-lactalbumin to the apoptosis inducing form in the presence of oleic acid (3) . HAMLET is thus defined as the biologically active conversion product of α-lactalbumin and oleic acid.
4
One striking feature of HAMLET is the ability to move through the cytoplasm of tumor cells to the nuclei, where HAMLET remains and accumulates. This unusual trafficking behavior was first observed in early studies with the active human milk fraction (2, 4) . The nuclear accumulation occurred in the majority of dying tumor cells but not in the healthy cells that remained viable in the presence of HAMLET, showing that the interaction with the nuclear compartment is an important aspect of the tumor cell response. In addition, the nuclear accumulation appeared to be irreversible, suggesting that nuclear target molecules were able to bind and retain the active complex in the nucleus.
The present study identified nuclear target molecules for HAMLET in cancer cells. We present evidence that HAMLET interacts with specific histone proteins and chromatin. The chromatin interaction may indeed mark the irreversible phase of cell death.
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EXPERIMENTAL PROCEDURES
Purification of α-lactalbumin and conversion to HAMLET-HAMLET is a folding variant of human α-lactalbumin stabilized by a C18:1 fatty acid cofactor. In this study, native α-lactalbumin was purified from human milk and converted to HAMLET on an oleic acid conditioned ion exchange matrix as previously described (3).
Protein labeling-HAMLET was labeled with 125 I (ICN Biomedicals, Irvine, CA, USA) using the lacto-peroxidase method as previously described (4) . HAMLET was labeled with Alexa Fluor 568 according to manufacturer's instructions (Molecular Probes Inc., Eugene, OR, USA).
Cell culture-A549 (ATCC, CLL 185), Jurkat (European Cell Culture Collection, no. 88042803) and the primary HRTEC (Human Renal Tubular Epithelial) cells were cultured as described (1) .
HeLa cells were grown in Dulbeccos MEM with glutamax supplemented with penicillin (100U/ml)-streptomycin (100 µg/ml), Sodium Pyruvate (1 mM) (Invitrogen Gibco), 10% FCS and, for cells expressing green fluorescent protein (GFP)-tagged histones, 2 µg/ml blasticidin S (Invitrogen Gibco). Bound HAMLET was detected using a STORM 840 phosphor imager (Molecular Dynamics,
Subcellular localization of HAMLET-

Inc.).
Protein sequencing and identification-Nuclear extracts were blotted to PVDF membranes, stained with Coomassie blue and bands to be sequenced were excised and subjected to N- Mass spectrometry-The 12, 14, 16 and 17 kDa bands from the nuclear extract were excised from the gel and prepared for mass spectrometry with a Bruker Scout 384 Reflex III matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometer (10).
Histones-Individually purified bovine histones H1, H2A, H2B, H3 and H4 were purchased from Roche Diagnostics (Bromma, Sweden). Native, folded histones were obtained from duck erythrocyte nuclei (11). Drosophila melanogaster histones were expressed in E. coli, purified and assembled into octamers (12) . The nuclear accumulation of HAMLET was quantified using radio-labeled protein. Nuclear fractions were obtained from 125 I-HAMLET treated carcinoma cells after 1, 3 or 6 hours of incubation. About 90% of the cell associated radioactivity was in the nuclear fraction after one hour, with a little further increase at the later time points and 0.2 to 0.4% of the total added radioactivity was incorporated into the cells (Fig. 1B) . After 6 hours, cell viability had decreased to 67%.
HAMLET binds to specific histones in nuclear extracts-Molecular targets for HAMLET were identified in nuclear extracts separated by SDS-PAGE and overlaid with 125 I-HAMLET.
Experiments were performed in parallel in one human lymphoma (Jurkat) and one carcinoma (A549) cell line and similar results were obtained using nuclear extracts from both cell lines.
HAMLET was shown to recognize four distinct bands of approximately 12, 14, 16 and 17kDa molecular weight ( Fig. 2A) . band showed sequence homology with H3 but lacked the first 21 amino acids of the N-terminal tail ( Fig. 2A ). This form of H3 corresponds to a fragment obtained after proteolytic degradation, and as a consequence, the band was not recognized by the anti-H3 antibody which is directed to the tail region (not shown). HAMLET, in contrast, bound to this form of H3, suggesting that the interaction is independent of the histone tail.
HAMLET interacts with purified histones-These interactions were further examined using purified histone proteins. As a first step, purified bovine histones H1, H2A, H2B, H3 and H4
were separated by SDS-PAGE, blotted onto PVDF membranes and the blots were overlaid with radio-labeled HAMLET (Fig. 2B ). High affinity binding to H3 and weak binding to H4 and H2B was observed. HAMLET did not bind to bovine H1 or H2A in the overlay assay.
The histone specificity of HAMLET was further examined using natively folded histones in affinity chromatography. A mixture of core histones (H2A, H2B, H3 and H4) purified from duck erythrocyte nuclei was allowed to interact with HAMLET immobilized on CNBr-activated sepharose. Proteins eluted with SDS loading buffer were identified by SDS-PAGE. The four histones were retained on the column in approximately equal amounts but there was no binding to the clean sepharose matrix (Fig. 2C ).
The affinity of HAMLET for isolated histones was studied by surface plasmon resonance using HAMLET coated BIAcore sensor chips and bovine or natively folded duck histone preparations.
Bovine histone H3 showed very rapid binding kinetics, and remained bound with no evidence of dissociation during the experimental period, suggesting virtually irreversible binding to HAMLET (data not shown). H3 could not be forcibly eluted from the chip when detergents, salt or acid were used. The native core histones bound rapidly to the HAMLET coated surface (Fig.   2D ) and the dissociation was very slow.
HAMLET precipitates histones from solution-In preparation for studies of nucleosomes and chromatin, native core histones (H2A, H2B, H3 and H4) were mixed with HAMLET in solution.
To our surprise, the solution immediately turned opalescent and with time a white precipitate accumulated at the bottom of the test tube. The precipitate was analyzed by SDS-PAGE and was
shown to mainly contain histones H3 and H4 and minor amounts of H2A and H2B (Fig. 3) .
HAMLET was also present in the precipitates (not shown). Native α-lactalbumin was used as a control and did not form precipitates with the histones (Fig. 3 ) and the histones did not precipitate in the absence of HAMLET (not shown).
HAMLET co-localizes with histones H2B and H3 in vivo-
The interaction of HAMLET with histones was further examined in the nuclei of intact, living cells. Stably transfected HeLa cell lines expressing GFP-H3 or GFP-H2B were exposed to Alexa-HAMLET. By real-time confocal microscopy ( Fig. 4A) , HAMLET was shown to co-localize with both histones in the HeLa cell nuclei.
In addition, the global chromatin structure was perturbed by HAMLET treatment. In HAMLET treated cells, the chromatin was condensed to the nuclear periphery and new, spherical structures appeared. Both HAMLET and the histones were present in those structures. Control cells showed normal chromatin distribution (Fig. 4B) .
HAMLET is not a chromatin assembly protein-
The results suggested that HAMLET may interact directly with soluble histones and chromatin in tumor cells. HAMLET was compared with the chromatin assembly protein Nucleosome Assembly Protein 1 (NAP-1), which binds histones and delivers them to DNA, thereby enhancing nucleosome formation. NAP-1 was mixed with histones, DNA fragments were added to the mixture and the assembled nucleosomes were detected by native PAGE (Fig. 5A) . The pure histone-DNA mixture formed unspecific aggregates, but after addition of NAP-1, a concentration dependent nucleosome assembly was observed. Depending on the position of the histone octamer on the DNA fragment, two mononucleosome species were formed (bands N 1 and N 2 ). The same assay system was used to test how HAMLET affected the assembly of nucleosomes ( (Fig. 6 ).
DISCUSSION
HAMLET causes apoptosis-like death of tumor cells and accumulates in their nuclei. In this study, histones and chromatin were found to be the nuclear target molecules involved in this process. HAMLET was shown to bind a discrete set of proteins in nuclear extracts, which were identified as histones H3, H4 and H2B. The histone specificity of HAMLET was confirmed using isolated histone proteins and both denatured and natively folded histones were found to bind HAMLET. High affinity interactions were detected by BIAcore methodology, and A and B) .
Addition of NAP-1 (A, lanes 2-7) caused a concentration dependent nucleosome assembly (bands N 1 and N 2 ). Nucleosomes were not formed after addition of HAMLET (B, lanes 2-8). 
